Cell Death and Disease (Jan 2023)

Resveratrol rescues cutaneous radiation-induced DNA damage via a novel AMPK/SIRT7/HMGB1 regulatory axis

  • Yi Jin,
  • Xingyuan Liu,
  • Xiaoting Liang,
  • Jiabin Liu,
  • Jieyu Liu,
  • Zonglin Han,
  • Qianxin Lu,
  • Ke Wang,
  • Bingyao Meng,
  • Chunting Zhang,
  • Minna Xu,
  • Jian Guan,
  • Li Ma,
  • Liang Zhou

DOI
https://doi.org/10.1038/s41419-022-05281-y
Journal volume & issue
Vol. 13, no. 10
pp. 1 – 13

Abstract

Read online

Abstract Cutaneous radiation injury (CRI) interrupts the scheduled process of radiotherapy and even compromises the life quality of patients. However, the current clinical options for alleviating CRI are relatively limited. Resveratrol (RSV) has been shown to be a promising protective agent against CRI; yet the mechanisms of RSV enhancing radioresistance were not fully elucidated and limited its clinical application. In this study, we demonstrate RSV promotes cutaneous radioresistance mainly through SIRT7. During ionizing radiation (IR) treatment, RSV indirectly phosphorylates and activates SIRT7 through AMPK, which is critical for maintaining the genome stability of keratinocytes. Immunoprecipitation and mass spectrometry identified HMGB1 to be the key interacting partner of SIRT7 to mediate the radioprotective function of RSV. Mechanistic study elucidated that SIRT7 interacts with and deacetylates HMGB1 to redistribute it into nucleus and “switch on” its function for DNA damage repair. Our findings establish a novel AMPK/SIRT7/HMGB1 regulatory axis that mediates the radioprotective function of RSV to alleviate IR-induced cutaneous DNA injury, providing an efficiently-curative option for patients with CRI during radiotherapy.